Dr. Mattison's clinical interests are in the care of patients with hematologic malignancies, particularly acute lymphoblastic leukemia and acute myeloid leukemia. He is interested in drug development to improve care and outcomes for these patients.
Dr. Mattison’s research interests work with the Hematology Disease-Oriented Working Group, which makes novel treatments available to patients through investigator-initiated studies as well programs through the National Cancer Institute and pharmaceutical companies.